R. Michael Carruthers - Chief Financial Officer at Edgewise Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
EWTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

R. Michael Carruthers - trading volume in the past year for Edgewise Therapeutics, Inc.

Holdings reported by R. Michael Carruthers for Edgewise Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 86.2K $1.15M $13.39 Aug 12, 2025 Direct
Restricted Stock Units 26.9K $437K $18.91 Aug 12, 2025 Direct Common Stock
Stock Option (Right to Buy) 161K Aug 12, 2025 Direct Common Stock

Transactions reported by R. Michael Carruthers for Edgewise Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.